Fluconazole and Voriconazole Resistance in Candida parapsilosis Is Conferred by Gain-of-Function Mutations in MRR1 Transcription Factor Gene

被引：39
|
作者：
Branco, Joana [1 ]
Silva, Ana P. [1 ,2 ]
Silva, Raquel M. [3 ,4 ,5 ]
Silva-Dias, Ana [1 ,2 ]
Pina-Vaz, Cidalia [1 ,2 ]
Butler, Geraldine [6 ]
Rodrigues, Acacio G. [1 ,2 ]
Miranda, Isabel M. [1 ,2 ]
机构：
[1] Univ Porto, Fac Med, Dept Microbiol, P-4100 Porto, Portugal
[2] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, P-4100 Porto, Portugal
[3] Univ Aveiro, Inst Biomed iBiMED, P-3800 Aveiro, Portugal
[4] Univ Aveiro, IEETA, P-3800 Aveiro, Portugal
[5] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Porto, Portugal
[6] Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 10期
关键词：
ANTIFUNGAL DRUG-RESISTANCE; UP-REGULATION; MECHANISMS; OVEREXPRESSION; HETEROZYGOSITY; ORTHOPSILOSIS; METAPSILOSIS; REGULATOR;
D O I：
10.1128/AAC.00842-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Candida parapsilosis is the second most prevalent fungal agent causing bloodstream infections. Nevertheless, there is little information about the molecular mechanisms underlying azole resistance in this species. Mutations (G1747A, A2619C, and A3191C) in the MRR1 transcription factor gene were identified in fluconazole- and voriconazole-resistant strains. Independent expression of MRR1 genes harboring these mutations showed that G1747A (G583R) and A2619C (K873N) are gain-of-function mutations responsible for azole resistance, the first described in C. parapsilosis.
引用
收藏
页码：6629 / 6633
页数：5
相关论文
共 50 条
  • [41] Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
    Forbes, Lisa R.
    Vogel, Tiphanie P.
    Cooper, Megan A.
    Castro-Wagner, Johana
    Schussler, Edith
    Weinacht, Katja G.
    Plant, Ashley S.
    Su, Helen C.
    Allenspach, Eric J.
    Slatter, Mary
    Abinun, Mario
    Lilic, Desa
    Cunningham-Rundles, Charlotte
    Eckstein, Olive
    Olbrich, Peter
    Guillerman, R. Paul
    Patel, Niraj C.
    Demirdag, Yesim Y.
    Zerbe, Christa
    Freeman, Alexandra F.
    Holland, Steven M.
    Szabolcs, Paul
    Gennery, Andrew
    Torgerson, Troy R.
    Milner, Joshua D.
    Leiding, Jennifer W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (05) : 1665 - 1669
  • [42] Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence
    Ferrari, Selene
    Ischer, Francoise
    Calabrese, David
    Posteraro, Brunella
    Sanguinetti, Maurizio
    Fadda, Giovanni
    Rohde, Bettina
    Bauser, Christopher
    Bader, Oliver
    Sanglard, Dominique
    PLOS PATHOGENS, 2009, 5 (01)
  • [43] Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
    Paudel, Roshan
    Jafri, Mohsin Saleet
    Ullah, Aman
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (11) : 12886 - 12910
  • [44] Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): Chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding
    Frans, Glynis
    Moens, Leen
    Schaballie, Heidi
    Van Eyck, Lien
    Borgers, Heleen
    Wuyts, Margareta
    Dillaerts, Doreen
    Vermeulen, Edith
    Dooley, James
    Grimbacher, Bodo
    Cant, Andrew
    Declerck, Dominique
    Peumans, Marleen
    Renard, Marleen
    De Boeck, Kris
    Hoffman, Ilse
    Francois, Inge
    Liston, Adrian
    Claessens, Frank
    Bossuyt, Xavier
    Meyts, Isabelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (05) : 1209 - 1213
  • [45] Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
    Vargas-Hernandez, Alexander
    Mace, Emily M.
    Zimmerman, Ofer
    Zerbe, Christa S.
    Freeman, Alexandra F.
    Rosenzweig, Sergio
    Leiding, Jennifer W.
    Torgerson, Troy
    Altman, Matthew C.
    Schussler, Edith
    Cunningham-Rundles, Charlotte
    Chinn, Ivan K.
    Carisey, Alexandre F.
    Hanson, Imelda C.
    Rider, Nicholas L.
    Holland, Steven M.
    Orange, Jordan S.
    Forbes, Lisa R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (06) : 2142 - +
  • [46] Loss-of-function mutations in the Transcription Factor 7 (T cell factor-1) gene in hepatogastrointestinal cancers
    Jung, Kwang Hwa
    Yoon, Kang Jun
    Song, Jae Hwi
    Lee, Sung Hak
    Eun, Jung Woo
    Noh, Ji Heon
    Kim, Jeong Kyu
    Bae, Hyun Jin
    Lee, Jang Eun
    Kim, Sang Woo
    Choi, Myung Gyu
    Kim, Su Young
    Park, Won Sang
    Nam, Suk Woo
    Lee, Jung Young
    MOLECULAR & CELLULAR TOXICOLOGY, 2010, 6 (03) : 271 - 278
  • [47] Loss-of-function mutations in the Transcription Factor 7 (T cell factor-1) gene in hepatogastrointestinal cancers
    Kwang Hwa Jung
    Kang Jun Yoon
    Jae Hwi Song
    Sung Hak Lee
    Jung Woo Eun
    Ji Heon Noh
    Jeong Kyu Kim
    Hyun Jin Bae
    Jang Eun Lee
    Sang Woo Kim
    Myung Gyu Choi
    Su Young Kim
    Won Sang Park
    Suk Woo Nam
    Jung Young Lee
    Molecular & Cellular Toxicology, 2010, 6 : 271 - 278
  • [48] Gain-of-function STAT1 mutation decreases STAT3-inducible gene transcription in patients with Chronic Mucocutaneous Candidiasis (CMC)
    Zheng, J.
    Rowan, D.
    Gennery, A.
    Abinun, M.
    Lilic, D.
    IMMUNOLOGY, 2013, 140 : 167 - 167
  • [49] PDR2 gain-of-function mutations eliminate the need for Pdr1 and require the UBP6 product for resistance to translational inhibitors
    Keeven, J
    Ko, D
    Shallom, J
    Uccelini, B
    Golin, J
    CURRENT GENETICS, 2002, 41 (01) : 11 - 19
  • [50] PDR2 Gain-of-function mutations eliminate the need for Pdr1 and require the UBP6 product for resistance to translational inhibitors
    James Keeven
    Daejin Ko
    Joshua Shallom
    Beth Uccelini
    John Golin
    Current Genetics, 2002, 41 : 11 - 19
12345